Evidence map›Paper›PMID 36699020›Full record

ReviewFrontiers in endocrinology2022

Diabetic retinopathy: Looking forward to 2030.

Tien-En Tan, Tien Yin Wong

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 278 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
278citing papers in PubMed, 8 pooled it
122.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06272851 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Comparing the Choroidal Thickness Using Optical Coherence Tomography Between the Eyes of Healthy Individuals and Diabetic Patients Without Retinopathy

TypeobservationalSponsorAssiut UniversityRan2024 to 2029Enrolled122ConditionsChoroid Disease, Diabetes MellitusArmsoptical coherence tomography
NCT07640256 phase4completednot on this mapstarted 2023, after this paper: background citation

Safety and Efficacy of Peribulbar Anesthesia for Pain Management in Patients With Proliferative Diabetic Retinopathy During Panretinal Photocoagulation

TypeinterventionalSponsorAsociación para Evitar la Ceguera en MéxicoRan2023 to 2024Enrolled50ConditionsProliferative Diabetic RetinopathyArmsPeribulbar anesthesia with 0.5% bupivacaine and 2% lidocaine, Tetracaine 5% drops
3 · Its place in the literature

Who cites it

278 citing papers in PubMed, 8 syntheses or guidelines pooled it, 436 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Toward Reliable Diabetic Retinopathy Screening.Sensors (Basel, Switzerland) · 2026
    Article
  19. Article
  20. Article

218 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Tien-En TanSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Tien Yin WongSingapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
Singapore National Eye Center · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is the major ocular complication of diabetes mellitus, and is a problem with significant global health impact. Major advances in diagnostics, technology and treatment have already revolutionized how we manage DR in the early part of the 21

Indexed as

Diabetes MellitusDiabetic RetinopathyArtificial IntelligenceEyeHumansTomography, Optical Coherenceartificial intelligenceclassification and staging systemdiabetic retinopathyepidemiologyfuture trends and predictionsimaging modalitiesnew treatmentspathophysiology

Identifiers

PMID36699020
PMCPMC9868457
OpenAlexW4313827473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.